Neudle.com: Parkinson disease motor fluctuations

Differential
(Click to cross reference)

abdominal protrusion

abducens nerve paralysis

abiotrophy

acoustic nerve

acoustic neurinoma

activities of daily living

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

affect, flat

akinesia of eyelid function

akinetic mute

alcohol

alcohol intolerance

alcoholic polyneuropathy

alpha and gamma motor system

alpha-synuclein

altered states of consciousness

altered states of consciousness, driving with

alternating hemiplegia

alternating hemiplegia of childhood

Alzheimer's disease

amantadine

amblyopia, toxic

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, childhood

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, Parkinson-dementia-complex

amyotrophic lateral sclerosis, post-encephalitic

amyotrophic lateral sclerosis, treatment of

anesthesia, general

aneurysm, cavernous sinus

aneurysm, internal carotid artery

angiography, cerebral

ankylosing spondylitis

anomic aphasia

anorexia

anosmia

anti basal ganglia antibodies

anti IgLON5

anticholinergic drugs

anticholinergic drugs, side effects of

aphasia, progressive, primary

aphasia, transcortical

aphasia, transcortical-motor

apomorphine

applause sign

apraxia

apraxia of eye movements

apraxia of eyelid opening

atlanto axial dislocation, congenital

atonic bladder

ATP1A3 gene

attention deficit disorder with hyperactivity

atypical

auditory and vestibular pathways

autoantibodies

automobile accidents

autonomic dysfunction

Babinski sign

basal ganglia

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

benign essential tremor, refractory

benserazide

beta adrenergic blocker

bilirubin encephalopathy

blood dyscrasias, neurologic findings with

botulinum toxin

brachial neuritis

brachial neuritis, acute

brainstem, infarction of

brainstem, lesion of

Broca's aphasia

bromocriptine

Brown Sequard syndrome

bulbar palsy

burning paresthesia

cabergoline

calcification, intracranial

camptocormia

carbidopa

carbon monoxide poisoning

CAT scan, angiography

CAT scan, angiography, false negative

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, venography

cataplexy

cataracts

catechol-o-methyltransferase inhibitor

cavernous sinus, syndrome

central hypoventilation

central nervous system, infection of

cerebellar atrophy, primary

cerebellar disease, eye movement disorder in

cerebellar lesion

cerebellum, neoplasms of

cerebral cortical atrophy

cerebral edema

cerebral embolism

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, pressure low

cerebrovascular accident

cerebrovascular accident, nonarterial territory

ceruloplasmin, serum

Charcot-Marie-Tooth

Charcot's sign

chemotherapy, CNS treatment and complications with

chromosomal abnormality

chromosome 6

chronic progressive external ophthalmoplegia

cingulate island sign

Clinical Pathologic Conference(C.P.C.)

cogwheel pursuit movements

convergence, impaired

cortical-basal ganglionic degeneration

cost effectiveness

cough

cranial neuropathy

cranial neuropathy, multiple

crush syndrome

crying, pathologic

cryoglobulinemia

cultured skin fibroblasts

cycad seed flour

cycling

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

delusion

dementia

dementia, age at onset

dementia, frontal lobe type

dementia, frontotemporal

dementia, presenile

dementia, rapidly progressive

dementia, thalamic

deprenyl

depression

developmental retardation

diabetes mellitus

diagnostic criteria

diet

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

dopamine receptor, D2

downward gaze

downward gaze, paralysis of

drug abuse, neurologic complications of

drug addiction

drug induced neurologic disorders

dural arteriovenous malformation

dysarthria

dysdiadochokinesia

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

electroencephalogram, abnormalities of

electron microscopy

electronystagmography, abnormal

emotional lability

encephalitis

encephalitis lethargica

encephalitis, viral

encephalocele

encephalopathy

encephalopathy, delayed

encephalopathy, neonatal

encephalopathy, post anoxic

endocarditis, subacute bacterial

entacapone

enzyme inhibition

epidemiology of neurology

evidence-based research

executive dysfunction

exercise

exercise intolerance

exome sequencing

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial nerve palsy

facial nerve palsy, bilateral

facial pain

failed medical management

fine motor function, impaired

fingerprint bodies

fistula, arterio-venous, dural

frontal behavioral spatial syndrome

frontal lobe, behavior with disease of

frontotemporal dementia, behavioral variant

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus focused ultrasound ablation

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

globus pallidus, stimulation

grasp reflex

grimacing

guanfacine

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination

hallucination, visual

hematoma, intracerebral

hepatolenticular degeneration(Wilson's disease)

hepatomegaly

hepatosplenomegaly

heralding manifestation

hyperbilirubinemia, CNS abnormality after

iatrogenic neurologic disorders

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inattention

inclusion bodies

incontinence, fecal

infantile tremor syndrome

inflexibility, mental

injection neuropathy

insomnia

intellectual deficit

intellectual deterioration

internet

internuclear ophthalmoplegia

intracerebral hemorrhage

intracranial pressure, increased

intranasal medication

iron, brain

isoniazid

Jackson's syndrome

Jakob-Creutzfeldt disease

Kayser-Fleischer ring

kernicterus

kinesia paradoxica

Korsakoff's psychosis

lactic acidemia

language disorder in adults

laser shoes

laughing, pathologic

L-dopa

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, liquid

L-dopa, plasma concentration

L-dopa, potentiators of

leukemia, neurologic findings assoc.with

leukoencephalopathy

levitation

Lewy body

Lewy body disease, diffuse

life expectancy

lipid storage disorder of CNS

lithium

livedo reticularis

liver disease

liver transplantation

lobar atrophy

logopenia

loss of sympathy

lumbar puncture, complications of

madopar

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

marche a petits pas

masked facies

MELAS syndrome

memory, impairment of

meningismus

meningitis

meningitis, carcinomatous

meningoencephalitis

meningoencephalopathy

methotrexate

methylhydrazine derivatives

microcephaly

micrographia

microhemorrhage, intracerebral

migratory lesion pattern

Millard Gubler syndrome

mimics

misdiagnosis

mitochondrial disease

mitochondrial disease, pathogenesis

mitochondrial encephalomyopathy

molecular genetics

monoamine oxidase inhibitors

motor neuron disease, juvenile form

movement disorder

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

MRI

MRI, abnormal

MRI, angiography

MRI, angiography, false negative

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, eye of tiger sign

MRI, paramagnetic effect

MRI, perfusion

MRI, serial

MRI, susceptibility weighted

MRI, venography

multiple sclerosis

multiple sclerosis, treatment of

multiple system atrophy

neoplasm, primary of CNS

nerve growth factor

neuritis

neurodegeneration with brain iron accumulation

neurofilaments

neuroleptic

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications of, surgery

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, burden

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic signs

neurologic symptoms

neuronal ceroid-lipofuscinosis

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

neuroprotective agents

nystagmus, retractorius

nystagmus, vertical

obsessive-compulsive disorder

ocular motility, disorders of

ocular myopathy

ocular myopathy, differential diagnosis

oculogyric crisis

old age, neurology of

opened mouth

ophthalmoplegia

ophthalmoplegia, painful

ophthalmoplegia, progressive external

ophthalmoplegia, total

optic atrophy

optokinetic nystagmus, abnormal

organomegaly

orthostatic hypotension

pain

pain, increased response

parietal lobe, atrophy

Parkinson disease

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, diagnosis

Parkinson disease, diet restricted in protein

Parkinson disease, differential diagnosis of

Parkinson disease, driving with

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, incidence

Parkinson disease, intractable

Parkinson disease, late onset

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, motor neuron disease with

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, psychogenic

Parkinson disease, self-assessment

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism syndrome

Parkinsonism-dementia complex

paroxysmal hemiplegia

paroxysmal neurologic deficits

patient information and support

penguin silhouette sign

perceptual-motor dysfunction

pergolide

periodic paralysis

periodic paralysis, thyrotoxic

PHNO, enteral infusion, continuous

pleocytosis of cerebrospinal fluid

POLG1 gene

poliomyelitis

polymerase chain reaction

posterior cortical atrophy

posterior fossa, differential diagnosis of lesions of

posterior inferior cerebellar artery syndrome

practice guidelines

pramipexole

pramipexole, extended release

precipitating factors

preclinical

premature infant

pretectal syndrome

prevention of neurologic disorders

progressive infantile poliodystrophy

progressive neurologic disorder

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychomotor retardation

pursuit eye movements, abnormal

putamen, lesion of

putamen, lesion of, bilateral

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

rasagiline

reading disorder, acquired

reading problem, causes of

recurrent

rehabilitation for neurologic disorders

release phenomena

REM sleep behavior disorder

renal failure

reserpine and reserpine like drugs

respirations in CNS disease

risk-benefit assessment

ropinirole

ropinirole, prolonged release

saccadic eye movements

saccadic eye movements, abnormal

safety

salivation, excessive

schizophrenia

screening

seizure

seizure, laughing as manifestation

sensorineural hearing loss

sensory loss

sensory loss, cortical

sequencing difficulty

sinemet

single photon emission computed tomography

skin, biopsy

sleep apnea, obstructive

sleep pathology and physiology

slit lamp examination

smell

Smell Identification Test

somnolence

speech disorder

speech disorder, non aphasic

speech, loss of

speech, soft

spina bifida

spinal cord, blood supply of

spinal muscular atrophy

spinocerebellar ataxia

spinocerebellar ataxia type 3/Machado Joseph disease

stem cell transplantation

stereotaxic surgery

stereotyped behavior

stimulation, deep brain

stress, emotional

striatonigral degeneration

striopallidodentate calcifications, familial idiopathic

strokelike episodes

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subarachnoid hemorrhage

subdural hematoma

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

syphilis, neurologic complications with

temporal lobe, atrophy

term infant

thalamotomy

thalamus, focused ultrasound ablation

thalamus, lesion of

thalamus, lesion of-bilateral

tic

tic, classification of

treatment of neurologic disorder

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

trigeminal neuralgia

trinucleotide repeats

twins

Unified Parkinson Rating Scale

upgaze, paralysis of

urinary incontinence

urine test for metabolic disorders

vincristine neurotoxicity

viral infection

viral infection, CNS

vision, blurred

vision, failure of in childhood

visual acuity, decreased

visual impairment

visual loss

visual loss, progressive

walking, difficulty with

whole genome sequencing

Wolff-Parkinson-White syndrome

word-finding difficulty

Showing articles 50 to 100 of 4191 << Previous Next >>

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

Ophthalmologic Features of Parkinson's Disease
Neurol 62:177-180, Biousse,V.,et al, 2004

Stalevo for Parkinson's Disease
The Medical Letter 46:39, , 2004

Dementia with Lewy Bodies
Lancet 362:1689-1690, Wilcock,G.K., 2003

Treatments of Parkinson Disease
Arch Neurol 60:1680-1684, Shults,C.W., 2003

Driving Safety in Parkinson's Disease
Neurol 59:1787-1788, Zesiewicz,T.A.,et al, 2002

Subthalamic DBS Replaces Levodopa in Parkinson's Disease
Neurol 58:396-401, Vingerhoets,F.J.G.,et al, 2002

Nonmotor Fluctuations in Parkinson's Disease
Neurol 59:408-413, Witjas,T.,et al, 2002

Surgical Therapy for Tremor in Multiple Sclerosis
Neurol 57:1876-1882, Matsumoto,J.,et al, 2001

Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001

A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001

What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000

Niemann-Pick Disease Type C: Two Cases and an Update
Movement Disorders 15:1199-1203, Uc,E.Y.,et al, 2000

Language Disturbances in Corticobasal Degeneration
Neurol 54:990-992, Frattali,C.M.,et al, 2000

Botulinum Toxin is a Useful Treatment in Excessive Drooling of Saliva
JNNP 67:697, Bhatia,K.P.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Bilateral Substantia Nigra Changes on MRI in a Patient with Encephalitis Lethargica
Neurol 53:1860-1862, Kun,L.N.,et al, 1999

Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999

Molecular Basis of the Neurodegenerative Disorders
NEJM 340:1970-1980, Martin,J.B., 1999

Stereotactic pallidotomy for Trtm of Parkinson's Disease, Efficacy & Adverse Effects at 6 Mo in 26 Pts
Neurol 50:434-438, Shannon,K.M.,et al, 1998

Assessment of Motor Function After Stereotactic Pallidotomy
Neurol 50:266-270, Ondo,W.G.,et al, 1998

Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998

Double-Blind Evaluation of Subthalamic Nucleus Deep Brain Stimulation in Advanced Parkinson's Disease
Neurol 51:850-855, Kumar,R.,et al, 1998

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998

Bilateral High-Frequency Stimulation of the Internal Globus Pallidus in Advanced Parkinson's Disease
Ann Neurol 44:953-961, Volkmann,J.,et al, 1998

Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998

Familial Idiopathic Brain Calcification with Autosomal Dominant Inheritance
Neurol 48:645-649, Kobari,M.,et al, 1997

Clinicopath Conf
Progressive Supranuclear Palsy, Case 26, 1997, NEJM 337:549-55697., , 1997

Familial Nature and Continuing Morbidity of the Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex of Guam
Neurol 49:400-409, McGeer,P.L.,et al, 1997

COMT Inhibition with Tolcapone Reduces the"Wearing Off"Phenomenon & Levodopa Requirements in Fluctuating Parkinsonisn Pts
JNNP 63:421-428, Baas,H.,et al, 1997

Tolcapone Improves Motor Function in Parkinsonian Pts with the"Wearing Off"Phenomenon
Neurol 49:1066-1071, Rajput,A.H.,et al, 1997

Entacapone Improves Motor Fluctuations in Levodopa-Treated Parkinson's Dis Pts
Parkinson Study Group, Ann Neurol 42:747-7551997., , 1997

Nonmotor Fluctuations in Patients with Parkinson's Disease
Neurol 47:1180-1183, Hillen,M.E.&Sage,J.I., 1996

Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996

Neuropsychiatric Aspects of Progressive Supranuclear Palsy
Neurol 47:1184-1189, Litvan,I.,et al, 1996

Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Decreased SPECT[123I]B-CIT Striatal Uptake Correlates with Symptom Severity in Parkinson's Disease
Ann Neurol 38:589-598, Seibyl,J.P.,et al, 1995

Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Fluctuating Parkinson's Disease:Treatment with the Long-Acting Dopamine Agonist Cabergoline
Arch Neurol 51:1236-1241, Ahlskog,J.E.,et al, 1994

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

Eye Movements in Parkinsonian Syndromes:Vidailhet
M. , et al, Neurol 35:420-42694., , 1994

The Spectrum of Levodopa-Related Fluctuations in Parkinson's Disease
Neurol 43:1459-1464, Riley,D.E.&Lang,A.E., 1993

Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa
Neurol 43:1981-1984, Lieberman,A.,et al, 1993

Showing articles 50 to 100 of 4191 << Previous Next >>